Lerner SP - Search Results

1

Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma.

Shariat SF, Kim JH, Andrews B, Kattan MW, Wheeler TM, Kim IY, Lerner SP, Slawin KM. Shariat SF, et al. Among authors: lerner sp. Cancer. 2001 Dec 15;92(12):2985-92. doi: 10.1002/1097-0142(20011215)92:12<2985::aid-cncr10175>3.0.co;2-5. Cancer. 2001. PMID: 11753975

2

Two molecular pathways to transitional cell carcinoma of the bladder.

Spruck CH 3rd, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmütte C, Yang AS, Cote R, et al. Spruck CH 3rd, et al. Among authors: lerner sp. Cancer Res. 1994 Feb 1;54(3):784-8. Cancer Res. 1994. PMID: 8306342

3

Role of chromosome 9 in human bladder cancer.

Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH 3rd, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA. Miyao N, et al. Among authors: lerner sp. Cancer Res. 1993 Sep 1;53(17):4066-70. Cancer Res. 1993. PMID: 8358736

4

Adenovirus-mediated suicide gene therapy for experimental bladder cancer.

Sutton MA, Berkman SA, Chen SH, Block A, Dang TD, Kattan MW, Wheeler TM, Rowley DR, Woo SL, Lerner SP. Sutton MA, et al. Among authors: lerner sp. Urology. 1997 Feb;49(2):173-80. doi: 10.1016/S0090-4295(96)00560-2. Urology. 1997. PMID: 9037277

5

Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer.

Eastham JA, Kattan MW, Groshen S, Scardino PT, Rogers E, Carlton CE Jr, Lerner SP. Eastham JA, et al. Among authors: lerner sp. J Clin Oncol. 1997 Oct;15(10):3214-22. doi: 10.1200/JCO.1997.15.10.3214. J Clin Oncol. 1997. PMID: 9336358

6

Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology.

Ohori M, Abbas F, Wheeler TM, Kattan MW, Scardino PT, Lerner SP. Ohori M, et al. Among authors: lerner sp. J Urol. 1999 Feb;161(2):500-4. J Urol. 1999. PMID: 9915435

7

The loss of expression of transforming growth factor-beta receptors correlates with the histopathologic tumor grade in bladder transitional cell carcinoma patients.

Lee DH, Yang SC, Hong SJ, Chung BH, Chung HJ, Tokunaga H, Kim IY, Song YS, Lerner SP, Morton RA Jr. Lee DH, et al. Among authors: lerner sp. Yonsei Med J. 1999 Apr;40(2):118-23. doi: 10.3349/ymj.1999.40.2.118. Yonsei Med J. 1999. PMID: 10333714 Free article.

8

Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.

Tokunaga H, Lee DH, Kim IY, Wheeler TM, Lerner SP. Tokunaga H, et al. Among authors: lerner sp. Clin Cancer Res. 1999 Sep;5(9):2520-5. Clin Cancer Res. 1999. PMID: 10499628

9

In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer.

Sutton MA, Freund CT, Berkman SA, Dang TD, Kattan MW, Wheeler TM, Rowley DR, Lerner SP. Sutton MA, et al. Among authors: lerner sp. Mol Ther. 2000 Sep;2(3):211-7. doi: 10.1006/mthe.2000.0119. Mol Ther. 2000. PMID: 10985951 Free article.

10

Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.

Shariat SF, Weizer AZ, Green A, Laucirica R, Frolov A, Wheeler TM, Lerner SP. Shariat SF, et al. Among authors: lerner sp. Urology. 2000 Nov 1;56(5):735-40. doi: 10.1016/s0090-4295(00)00756-1. Urology. 2000. PMID: 11068290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters